Hudson TechnologiesNASDAQ: HDSN

Hudson Pacific Properties suspended its common shareholder dividend due to rising vacancy rates and weak demand for studio space post-2023 Hollywood strikes. HPP's Q3 2024 revenue dropped 13.4% year-over-year, missing estimates by $12.7 million, while FFO fell to $0.11 per share. The Company faces significant debt maturities, with $600 million due in 2025 and $976 million in 2026, amid a challenging San Francisco office market.

Hudson Pacific Properties has faced significant challenges, particularly in its office and studio segments, but its current valuation presents an attractive risk-reward proposition for patient investors. The company's portfolio of Class A office properties, primarily in Coastal markets, is showing signs of recovery with increasing leasing activity and stable rent economics. The studio business, despite current underperformance, has potential for substantial NOI growth, especially with the proposed expansion of California's film tax credit program.

OLD GREENWICH, Conn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, announced today financial results for the third quarter ended September 30, 2024.

OLD GREENWICH, Conn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Hudson RPO, a leading global total talent solutions company owned by Hudson Global, Inc. (NASDAQ: HSON) (the “Company”), announced today that it was named as the No.

Kris Bennatti, Hudson Labs CEO and co-founder, joins 'Fast Money' to talk its red flags it saw in Super Micro years ago.

Despite a 36% drop in Hudson Technologies' stock, I remain long, buying more after a 20% post-earnings drop due to strong fundamentals. Hudson holds 35% of the refrigerant reclamation market, benefiting from the AIM Act's phase down of virgin HFC production, ensuring long-term demand for reclaimed refrigerants. Financials show a 19% YoY revenue decline and margin pressure, but Hudson's balance sheet is strong with $56.5M in cash, no debt, and a buyback program.

Hudson Technologies (HDSN) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.34 per share a year ago.

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz.

WOODCLIFF LAKE, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced that its board of directors has approved an increase to the Company's share repurchase program. Hudson may now purchase up to $20 million in shares of its common stock, consisting of up to $10 million in shares during each of calendar year 2024 and 2025. The Company had previously announced that its board had authorized the repurchase of $10 million of outstanding common stock during 2024 and 2025.